Valatan

Valatan

valsartan

Manufacturer:

Healthcare Pharma

Distributor:

Labmate Pharma
Concise Prescribing Info
Contents
Valsartan
Indications/Uses
Management of HTN to reduce CV mortality in patients w/ left ventricular dysfunction after MI; heart failure.
Dosage/Direction for Use
HTN 80 mg once daily, may increase to 160-320 mg (max) if BP is not adequately controlled. Heart failure 40 mg bid, titrate to 80 mg & 160 mg bid of at least 2 wk intervals & as tolerated by patient. MI Initially 20 mg bid, titrated to 40, 80 & 160 mg bid.
Administration
May be taken with or without food.
Contraindications
Special Precautions
Concomitant use w/ an ACE inhibitor & β-blocker is not recommended in patients w/ heart failure. Renal & hepatic insufficiency. Should not be used during pregnancy. Not recommended during lactation.
Adverse Reactions
Dizziness, coughing, diarrhea, nausea.
MIMS Class
Angiotensin II Antagonists
ATC Classification
C09CA03 - valsartan ; Belongs to the class of angiotensin II receptor blockers (ARBs). Used in the treatment of cardiovascular disease.
Presentation/Packing
Form
Valatan FC tab 160 mg
Packing/Price
30's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in